Notably, treatments of ALS mice with several known AMPK activators (e.g., resveratrol, latrepirdine, and metformin) were shown to delay disease progression and enhance the survival of motor neurons [58, 256, 263]. The gene discussed is PRKAA2; the disease is amyotrophic lateral sclerosis.